PAMU
Pictet Asset Management (UK) Portfolio holdings
AUM
$91.6B
1-Year Return
47.74%
This Quarter Return
+9.36%
1 Year Return
+47.74%
3 Year Return
+102.22%
5 Year Return
+188.39%
10 Year Return
–
AUM
$55.9B
AUM Growth
+$8.79B
(+19%)
Cap. Flow
+$5.32B
Cap. Flow
% of AUM
9.51%
Top 10 Holdings %
Top 10 Hldgs %
11.99%
Holding
1,129
New
130
Increased
444
Reduced
476
Closed
37
Top Buys
| 1 |
UBS Group
UBS
|
+$311M |
| 2 |
Johnson Controls International
JCI
|
+$207M |
| 3 |
Pentair
PNR
|
+$194M |
| 4 |
Logitech
LOGI
|
+$189M |
| 5 |
Aptiv
APTV
|
+$188M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
+$184M |
| 2 |
Apple
AAPL
|
+$162M |
| 3 |
Global Payments
GPN
|
+$106M |
| 4 |
Digital Realty Trust
DLR
|
+$68.1M |
| 5 |
Booking.com
BKNG
|
+$58.4M |
Sector Composition
| 1 | Technology | 21.66% |
| 2 | Healthcare | 15.83% |
| 3 | Utilities | 14.13% |
| 4 | Industrials | 12.26% |
| 5 | Financials | 8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Essent Group
ESNT
$6.24B
| $35.7M | 0.06% |
+687,538
| New | +$35.7M |
|
327
Capital One
COF
$143B
| $35.6M | 0.06% |
346,136
-54,401
| -14% | -$5.6M |
|
328
NCR Voyix
VYX
$1.73B
| $35.6M | 0.06% |
1,649,107
-511,494
| -24% | -$11M |
|
329
Elevance Health
ELV
$69.1B
| $35.5M | 0.06% |
117,561
-2,127
| -2% | -$642K |
|
330
Aon
AON
$78.1B
| $35.4M | 0.06% |
170,063
-3,536
| -2% | -$737K |
|
331
Gaotu Techedu
GOTU
$865M
| $35.4M | 0.06% |
+1,619,056
| New | +$35.4M |
|
332
United Therapeutics
UTHR
$17.9B
| $35.4M | 0.06% |
401,832
-1,430
| -0.4% | -$126K |
|
|
AGN
333
DELISTED
Allergan plc
AGN
| $35.2M | 0.06% |
+149,986
| New | +$35.2M |
|
|
DCPH
334
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $35.1M | 0.06% |
563,259
+103,397
| +22% | +$6.44M |
|
|
CTT
335
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $34.6M | 0.06% |
3,014,189
+3,245
| +0.1% | +$37.2K |
|
336
Micron Technology
MU
$157B
| $34.4M | 0.06% |
639,126
-109,935
| -15% | -$5.91M |
|
337
Charter Communications
CHTR
$35.9B
| $34.3M | 0.06% |
70,662
+8,415
| +14% | +$4.08M |
|
338
Vistra
VST
$70.9B
| $33.8M | 0.06% |
1,471,484
+141,443
| +11% | +$3.25M |
|
339
Stryker
SYK
$146B
| $33.6M | 0.06% |
159,940
-31,280
| -16% | -$6.57M |
|
|
ARNA
340
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $33M | 0.06% |
725,717
-97,100
| -12% | -$4.41M |
|
341
DexCom
DXCM
$29.8B
| $32.5M | 0.06% |
593,856
-132,024
| -18% | -$7.22M |
|
342
Waters Corp
WAT
$17.4B
| $32.1M | 0.06% |
137,447
-52,605
| -28% | -$12.3M |
|
|
PRNB
343
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $32M | 0.06% |
583,276
+303,609
| +109% | +$16.6M |
|
344
Morgan Stanley
MS
$246B
| $31.9M | 0.06% |
624,609
-26,200
| -4% | -$1.34M |
|
345
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$30.7B
| $31.3M | 0.06% |
244,260
-1,650
| -0.7% | -$211K |
|
346
Veracyte
VCYT
$2.42B
| $31.3M | 0.06% |
1,119,427
+221,871
| +25% | +$6.19M |
|
347
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$13.9B
| $31.2M | 0.06% |
272,060
-24,840
| -8% | -$2.85M |
|
|
RETA
348
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $30.9M | 0.05% |
+151,062
| New | +$30.9M |
|
349
Coherent
COHR
$16.1B
| $30.8M | 0.05% |
914,926
+244,566
| +36% | +$8.23M |
|
|
CTXS
350
DELISTED
Citrix Systems Inc
CTXS
| $30.8M | 0.05% |
277,745
+4,249
| +2% | +$471K |
|